Inovio Pharmaceuticals Inc. Stock Slides 7.0%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. slipped 7.0% to $1.32 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.6% to 26,253.34 and Dow Jones Industrial Average falling 0.8% to 52,380.66.

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 55.7% short of its 52-week high of $2.98, which the company achieved on September 9th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.8% to $267.08, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. remained unchanged.

Trading volume totaled 2.7 million, compared to the 50-day average of 4.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 09, 2026 16:33 ET (20:33 GMT)